Furthermore, in study of advanced NSCLC, when the same IHC assay was used and PD-L1 was assessed by TPS and CPS, high agreement between these two scoring methods was detected (Kappa coefficient for adequacy was 0.82) [57]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.